Cancer patients with insulin-treated diabetes were four times more likely to die within a year of cancer diagnosis and had a fivefold increased odds of dying within five years of diagnosis compared with those without diabetes, a study revealed. Researchers also found patients on diabetes drugs alone had a 10% and 50% higher mortality risk two and five years after cancer diagnosis, respectively. The findings appear in Diabetologia.

Full Story:
HealthDay News

Related Summaries